HomeTECH • NASDAQ
add
BIO-TECHNE Corp
Previous close
$74.39
Day range
$72.72 - $75.13
Year range
$61.16 - $85.57
Market cap
11.40B USD
Avg Volume
1.09M
P/E ratio
79.64
Dividend yield
0.43%
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 289.46M | 4.52% |
Operating expense | 135.58M | 3.18% |
Net income | 33.60M | -34.11% |
Net profit margin | 11.61 | -36.94% |
Earnings per share | 0.42 | 2.44% |
EBITDA | 80.66M | -2.25% |
Effective tax rate | 16.36% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 187.54M | 26.15% |
Total assets | 2.74B | -0.70% |
Total liabilities | 597.37M | -21.15% |
Total equity | 2.14B | — |
Shares outstanding | 158.89M | — |
Price to book | 5.53 | — |
Return on assets | 4.83% | — |
Return on capital | 5.22% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 33.60M | -34.11% |
Cash from operations | 63.89M | 7.59% |
Cash from investing | -21.68M | 85.93% |
Cash from financing | -11.57M | -116.18% |
Net change in cash | 35.75M | 212.04% |
Free cash flow | 46.33M | 63.58% |
About
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. Wikipedia
Founded
1976
Headquarters
Website
Employees
3,100
